Evidence map›Paper›PMID 38396455›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Correlation between Histopathological Prognostic Tumor Characteristics and [

Jorianne Boers, Bertha Eisses, Mieke C Zwager, Jasper J L van Geel, Frederike Bensch, Erik F J de Vries, Geke A P Hospers, Andor W J M Glaudemans, Adrienne H Brouwers, Martijn A M den Dekker and 11 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Jorianne BoersDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.
Bertha EissesDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.ORCID 0000-0002-9288-0353
Mieke C ZwagerDepartment of Pathology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.
Jasper J L van GeelDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.ORCID 0000-0001-9045-8274
Frederike BenschDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.
Erik F J de VriesDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.ORCID 0000-0002-6915-1590
Geke A P HospersDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.
Andor W J M GlaudemansDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.ORCID 0000-0001-8081-0641
Adrienne H BrouwersDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.ORCID 0000-0003-2698-1516
Martijn A M den DekkerDepartment of Radiology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.
Sjoerd G EliasDepartment of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3584 Utrecht, The Netherlands.
Evelien J M KuipDepartment of Medical Oncology, Radboud Medical Center, 6500 Nijmegen, The Netherlands.
Carla M L van HerpenDepartment of Medical Oncology, Radboud Medical Center, 6500 Nijmegen, The Netherlands.
Agnes JagerDepartment of Medical Oncology, Erasmus MC Cancer Institute, 3015 Rotterdam, The Netherlands.
Astrid A M van der VeldtDepartment of Medical Oncology, Erasmus MC Cancer Institute, 3015 Rotterdam, The Netherlands.ORCID 0000-0003-0446-1907
Daniela E Oprea-LagerDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Location VU University Medical Center, 1081 Amsterdam, The Netherlands.
Elisabeth G E de VriesDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.
Bert van der VegtDepartment of Pathology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.ORCID 0000-0002-2613-1506
Willemien C Menke-van der Houven van OordtDepartment of Medical Oncology, Amsterdam University Medical Center, Location VU University Medical Center, 1081 Amsterdam, The Netherlands.ORCID 0000-0002-5404-5883
Carolina P SchröderDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.
IMPACT-Metastatic Breast Consortium
University Medical Center Groningen · NLErasmus MC Cancer Institute · NLUtrecht University · NL

Funding

Dutch Cancer Society 2012-5565
6 · The paper itself

Abstract

backgroundIn metastatic breast cancer (MBC), [ PATIENTS AND

methodsPatients with non-rapidly progressive MBC of all subtypes prospectively underwent a baseline histological metastasis biopsy and [

resultsOf 200 patients, 188 had evaluable metastasis biopsies, and 182 of these contained tumor. HER2 positivity and Ki-67 ≥ 20% were correlated with higher [

conclusions[

Indexed as

[18F]FDG-PETbreast cancerhistopathological characteristicsmetastases

Identifiers

PMID38396455
PMCPMC10887896
OpenAlexW4391843332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.